This content is machine translated Management of dyslipidemia Lipid-lowering agents for secondary prophylaxis also effective in elderly patients A recent meta-analysis published in the Lancet concluded that lipid lowering achieved comparable reductions in cardiovascular events in people over 75 years of age as in younger individuals. In elderly…
View Post 10 min This content is machine translated Rheumatism 2021 News from basic research Some important and interesting studies in the field of rheumatology in the last year are summarized. As in all fields, technical and analytical capabilities are accelerating exponentially in basic research.… CME-Test
View Post 3 min This content is machine translated Lipid Management Secondary prevention effective and safe even in elderly patients Elderly patients >75 years of age with existing atherosclerotic cardiovascular disease should be subjected to effective lipid lowering after considering their health status and with the help of regular follow-up.…
View Post 12 min This content is machine translated Heart failure Physical training in patients with HFrEF and HFpEF. The increasing prevalence of heart failure is a major medical and economic problem. The number of patients hospitalized for heart failure has been increasing for years. The clinical picture of… CME-Test
View Post 13 min This content is machine translated Gerontopsychiatry Focus on polypharmacy – challenges and solutions With age, diseases increase – and so does the likelihood of polypharmacy. However, this presents many challenges, as the heterogeneity and vulnerability of older people requires a differentiated approach. Patients… CME-Test
View Post 4 min This content is machine translated Blood pressure reduction How low for over 80s and frailty? In antihypertensive therapy in the 80-plus age group, it is important to weigh risk and benefit individually and not to treat strictly according to target values. Frailty (“frailness”) is an…
View Post 5 min This content is machine translated "Mild Cognitive Impairment" (MCI). How can progression be delayed? Patients with “Mild Cognitive Impairment” (MCI) have an increased risk of developing manifest dementia. The evidence on drug treatments that slow the progression of neurocognitive impairment is mixed. In terms of…
View Post 6 min This content is machine translated Swiss Association against Osteoporosis (SVGO) Toolbox for osteoporosis management: update of recommendations. Osteoporosis is a wide-ranging health problem, but there are a variety of preventive and therapeutic options available today. Early detection and risk stratification are important prerequisites for patient-adapted prevention and…
View Post 2 min This content is machine translated Neurodegenerative dementia Early diagnosis and effective therapy management in Alzheimer’s disease Alzheimer’s disease is the most common form of neurodegenerative disease in individuals over the age of 65 and is characterized by progressive dementia. The goal of current Alzheimer’s research is…
View Post 6 min This content is machine translated Osteoporosis Management New recommendations facilitate therapy selection for increased fracture risk Osteoporosis is severely underdiagnosed despite serious consequences, and many patients at increased risk of fracture remain untreated [1, 2]. The Swiss Association Against Osteoporosis (SVGO) now provides clear therapy recommendations…
View Post 13 min This content is machine translated Quantitative sensory testing in neuropathic pain. Comprehensive functional analysis of the somatosensory nervous system Pain is one of the most difficult symptoms to detect. Many other signs of disease, such as skin symptoms or paralysis, are visible, palpable, and thus objectifiable. In the assessment…
